KATHERINE HALL: Open Payments
NPI 1992257703 · BEAUFORT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 13 payments from 8 companies in 2025. Trend: 2023 $123 · 2024 $468 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Rybelsus, AIRSUPRA, GEMTESA, MOUNJARO, Dexcom G6 Transmitter, PREVNAR 20, Veozah, Wegovy.
Industry payments across SC — which companies pay providers there.
